Latest News and Press Releases

IRVINE, Calif., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, a family owned genetic testing Company, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance...

Lead product AMYNOPEP achieves proof-of-principle in exploratory clinical studyAMYNOPEP is the first and only gluten-digesting enzyme combination that supports and enhances the activity of critical...

Philadelphia, PA, Aug. 16, 2021 (GLOBE NEWSWIRE) -- The gluten-free diet is currently the only treatment for celiac disease, but it is far from a complete and effective intervention. That’s the...

Philadelphia, PA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading accelerator for a celiac disease cure in the United States, is pleased to support the Food Labeling Modernization Act...

Philadelphia, PA, July 27, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, today announced the granting of a two-year established...

Philadelphia, PA, July 01, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, announced that it has co-published research in an upcoming...

Philadelphia, PA, May 13, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, is celebrating Celiac Awareness Month this month with a...

Philadelphia, PA, March 31, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, announced today eye-opening data from its Go Beyond Celiac...

Philadelphia, PA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, today announced a two-year joint research grant program with...

Philadelphia, PA, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading accelerator for a celiac disease cure in the United States, sees a new study showing celiac disease patients face a...